Levomilnacipran Hydrochloride is a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant indicated for the clinical treatment of major depressive disorder in adults. This compound exerts its… Read more
Levomilnacipran Hydrochloride is a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant indicated for the clinical treatment of major depressive disorder in adults. This compound exerts its therapeutic effect by inhibiting the neuronal reuptake of serotonin and norepinephrine, effectively increasing synaptic concentrations to modulate mood and alleviate depressive symptoms. To support the rigorous analytical demands of pharmaceutical development, this category includes Levomilnacipran Hydrochloride reference standards, along with its associated pharmacopeial and non-pharmacopeial impurities. Laboratories utilize these high-quality materials for impurity profiling, method development, and validation during the quality control process. Additionally, the availability of stable isotope labelled compounds facilitates precise quantitative analysis through mass spectrometry, serving as essential internal standards for bioanalytical assays. By integrating these critical reference materials, researchers can ensure compliance with regulatory standards and maintain the accuracy of stability testing throughout the drug lifecycle.